US Patent 11161910 Glycated CD59 peptides, their preparation, and uses thereof

Patent 11161910 was granted and assigned to President and Fellows of Harvard College on November, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

President and Fellows of Harvard College

Current Assignee

‌

President and Fellows of Harvard College

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11161910

Date of Patent

November 2, 2021

Patent Application Number

20180601

Date Filed

June 1, 2018

Patent Citations Received

‌

US Patent 11891448 Glycated CD59 peptides, their preparation, and uses thereof

Patent abstract

The present invention provides glycated Amadori products of the CD59 peptide and fragments thereof to be used as tools and among methods for the diagnosis and prognosis of pre-diabetes and diabetes. Certain aspects of the invention include glycated Amadori products of CD59 and fragments thereof to be used for the generation of antibodies and antibody fragments. Still other aspects of the invention include methodologies for the preparation of glycated Amadori products of CD59, fragments thereof, the inventive antibodies, and antibody fragments.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11161910 Glycated CD59 peptides, their preparation, and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API